Revolutionizing Cancer Immunotherapy for Melanoma and Beyond
Researchers at Massachusetts General Hospital win a Breakthrough Award to enhance personalized approaches to immunotherapy for metastatic melanoma.
Melanoma is a disease of the skin in which cancer cells are found in the melanocytes, the cells that produce color in the skin or pigment known as melanin.
The Melanoma & Skin Cancer Surgery Program at Massachusetts General Hospital offers expert surgical care within a multidisciplinary Cancer Center team.
Melanoma
The Melanoma Center and Pigmented Lesion Center (PLC) at Massachusetts General Hospital is the nation's longest-standing multidisciplinary clinic providing care for patients with—or at risk of developing—cutaneous melanoma
Leading specialists in the Department of Radiation Oncology use advanced radiation therapy techniques to treat melanoma and other malignant skin tumors.
We help to identify and provide comprehensive, coordinated medical care for families that have a hereditary melanoma syndrome.
Skin cancer treatment at the internationally renowned Center for Melanoma offers novel therapies for individuals with advanced melanoma.
Through the process of tumor-infiltrating lymphocyte (TIL) therapy, a patient’s own TILs are reinvigorated to treat cancer. Mass General Cancer Center is one of the first centers to provide TIL therapy to patients with advanced melanoma.
Read the latest news from Massachusetts General Hospital.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.